[From left to right: Miguel Seabra, Pedro Póvoa, Winchil Vaz and João Conde]
CEDOC researchers Miguel Seabra, principal investigator of Molecular Mechanisms of Disease group, Pedro Póvoa, from Integrated Pathophysiological Mechanisms group, and Winchil Vaz, from Lysosomes in Chronic Human Pathology and Infection group, integrate the group of the most cited scientists worldwide in different disciplines, ranking in the top 2% in their respective fields. João Conde, from Cancer Nanomedicine group, presently working at CEDOC, also integrates this list.
This list is part of a study, conducted by Stanford University, and published latter October by PLOS Biology in the article entitled “Updated science-wide author databases of standardized citation indicators”. The study comprehended the analysis of standardized citation metrics from data between the mid-90s and 2019, using Scopus, an online database of articles and citations in several types of scientific publications. Within this study, a universe of 160.000 researchers from 149 countries in 22 scientific areas were identified.
Two lists were produced: the first one assessed the impact throughout the researchers’ career and the second one measured the impact in a single year (2019). As a result, this analysis allows the assessment of the influence of a scientist or institution in the progress of scientific knowledge.
The four distinguished researchers are unanimous when saying that being part of this list is rewarding, even if it is from diferent perspectives. While Miguel Seabra points out that “it is a recognition of the work of my team over the years and a reassurance that our work has had global impact”, Pedro Póvoa shares his experience in clinical research and concludes that “it is the result of more than 30 years of clinical and research work developed in parallel (…). I chose this path and this distinction shows that I made the right choice”. Winchil Vaz shares the impact this distinction has into the scientific endeavour as a whole: “There is no doubt in my mind that some of the work that I did along my career produced useful information that others could use to build up their work upon or justify their work with”. Finally, João Conde concludes that “[it] «raises the bar»” and suggests that: “(…) the price of greatness is a responsibility and we should never forget that our ultimate goal is to help improve the standard of care of more cancer patients on a bigger scale, help more people, create positive change on a bigger scale”.
Universidade NOVA de Lisboa occupies the third position among the national higher education and scientific research institutions assessed, presenting 32 researchers within the top 2% in their respective fields, which corresponds to 8,3% of the total national scientists (385 investigators) listed in the study. Find out more about the distinguished NOVA researchers here.